GMO Research & AI Beheer

Beheer criteriumcontroles 2/4

De CEO GMO Research & AI is Shinichi Hosokawa, benoemd in Sep2006, heeft een ambtstermijn van 18.17 jaar. bezit rechtstreeks 5.12% van de aandelen van het bedrijf, ter waarde ¥ 211.68M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 8.7 jaar en 8.7 jaar.

Belangrijke informatie

Shinichi Hosokawa

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	18.2yrs
Eigendom CEO	5.1%
Management gemiddelde ambtstermijn	8.7yrs
Gemiddelde ambtstermijn bestuur	8.7yrs

Recente managementupdates

Recent updates

Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings Quality

Aug 22

GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than Expected

Aug 07

CEO

Shinichi Hosokawa (51 yo)

18.2yrs

Tenure

Mr. Shinichi Hosokawa has been Chief Executive Officer and President at GMO Research, Inc since September 2006 and served as its General Manager of Internal Audit Office since January 2008. Mr. Hosokawa ha...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Shinichi Hosokawa	CEO, President & Director	18.2yrs	geen gegevens	5.12% ¥ 211.7m
Takenori Mori	MD, CFO	3.8yrs	geen gegevens	0.20% ¥ 8.1m
Tetsuya Hongo	Senior MD of Business Development Headquarters & Innovation HQ	8.7yrs	geen gegevens	0.27% ¥ 11.3m
Kenichiro Ando	GM of Global System Division	8.7yrs	geen gegevens	0.29% ¥ 12.1m
Yukiya Nagata	Chief Revenue Officer	no data	geen gegevens	0.061% ¥ 2.5m

8.7yrs

Gemiddelde duur

47yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 3695 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.7 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Shinichi Hosokawa	CEO, President & Director	18.7yrs	geen gegevens	5.12% ¥ 211.7m
Takenori Mori	MD, CFO	4.7yrs	geen gegevens	0.20% ¥ 8.1m
Tetsuya Hongo	Senior MD of Business Development Headquarters & Innovation HQ	8.7yrs	geen gegevens	0.27% ¥ 11.3m
Kenichiro Ando	GM of Global System Division	8.7yrs	geen gegevens	0.29% ¥ 12.1m
Yukiya Nagata	Chief Revenue Officer	2.7yrs	geen gegevens	0.061% ¥ 2.5m
Masashi Yasuda	Director	8.7yrs	geen gegevens	geen gegevens
Masatoshi Kumagai	Executive Chairman	22.6yrs	geen gegevens	geen gegevens
Masaji Hashimoto	Independent Outside Director	10.7yrs	geen gegevens	geen gegevens
Masatoshi Hamatani	Outside Corporate Auditor	10.7yrs	geen gegevens	geen gegevens
Hideyuki Matsui	Corporate Auditor	1.8yrs	geen gegevens	geen gegevens

8.7yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 3695 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.7 jaar).

GMO Research & AI Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

GMO Research, Inc., Annual General Meeting, Mar 18, 2024

GMO Research, Inc., Annual General Meeting, Mar 22, 2023

No independent directors

No independent directors

GMO Research, Inc., Annual General Meeting, Mar 18, 2022

GMO Research, Inc., Annual General Meeting, Mar 19, 2021

Recent updates

Third quarter 2024 earnings released: JP¥8.57 loss per share (vs JP¥38.59 profit in 3Q 2023)

GMO Research & AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings Quality

Second quarter 2024 earnings released: JP¥12.24 loss per share (vs JP¥11.64 profit in 2Q 2023)

GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than Expected

Investor sentiment deteriorates as stock falls 21%

GMO Research & AI, Inc. to Report Q2, 2024 Results on Aug 06, 2024

First quarter 2024 earnings released: EPS: JP¥56.31 (vs JP¥82.69 in 1Q 2023)

GMO Research, Inc. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: JP¥188 (vs JP¥218 in FY 2022)

GMO Research, Inc., Annual General Meeting, Mar 18, 2024

GMO Research, Inc. to Report Fiscal Year 2023 Results on Feb 05, 2024

Upcoming dividend of JP¥115 per share at 4.0% yield

Third quarter 2023 earnings released: EPS: JP¥38.59 (vs JP¥44.12 in 3Q 2022)

GMO Research, Inc. to Report Q3, 2023 Results on Nov 06, 2023

New major risk - Earnings quality

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: JP¥11.64 (vs JP¥43.51 in 2Q 2022)

GMO Research, Inc. to Report Q2, 2023 Results on Aug 03, 2023

First quarter 2023 earnings released: EPS: JP¥82.69 (vs JP¥107 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)

Investor sentiment deteriorates as stock falls 15%

Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)

GMO Research, Inc., Annual General Meeting, Mar 22, 2023

Upcoming dividend of JP¥116 per share

GMO Research, Inc. to Report Fiscal Year 2022 Results on Feb 06, 2023

No independent directors

Third quarter 2022 earnings released: EPS: JP¥44.12 (vs JP¥28.82 in 3Q 2021)

GMO Research, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: JP¥43.51 (vs JP¥14.11 in 2Q 2021)

GMO Research, Inc. to Report Q2, 2022 Results on Aug 04, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

GMO Research, Inc. to Report Q1, 2022 Results on May 09, 2022

First quarter 2022 earnings released: EPS: JP¥107 (vs JP¥64.39 in 1Q 2021)

No independent directors

GMO Research, Inc., Annual General Meeting, Mar 18, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of JP¥73.53 per share

Third quarter 2021 earnings released: EPS JP¥28.82 (vs JP¥25.76 in 3Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥64.39 (vs JP¥19.01 in 1Q 2020)

Investor sentiment improved over the past week

GMO Research, Inc. to launch new service brand “MO Lite”

GMO Research, Inc., Annual General Meeting, Mar 19, 2021

Full year 2020 earnings released: EPS JP¥107 (vs JP¥83.74 in FY 2019)

New 90-day low: JP¥1,645

GMO Research, Inc. to Report Q3, 2020 Results on Nov 06, 2020

GMO Research, Inc. to Report Q2, 2020 Results on Aug 07, 2020

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd